These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 38811795)

  • 1. Drug discovery for ageing: SIMPs, NEDs and screening challenges.
    Faragher RGA; Hartley RC
    Nat Rev Drug Discov; 2024 Oct; 23(10):725-726. PubMed ID: 38811795
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-ageing pipeline starts to mature.
    Mullard A
    Nat Rev Drug Discov; 2018 Sep; 17(9):609-612. PubMed ID: 30072728
    [No Abstract]   [Full Text] [Related]  

  • 3. An expedited screening platform for the discovery of anti-ageing compounds in vitro and in vivo.
    Lujan C; Tyler EJ; Ecker S; Webster AP; Stead ER; Martinez-Miguel VE; Milligan D; Garbe JC; Stampfer MR; Beck S; Lowe R; Bishop CL; Bjedov I
    Genome Med; 2024 Jul; 16(1):85. PubMed ID: 38956711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using the drug-protein interactome to identify anti-ageing compounds for humans.
    Fuentealba M; Dönertaş HM; Williams R; Labbadia J; Thornton JM; Partridge L
    PLoS Comput Biol; 2019 Jan; 15(1):e1006639. PubMed ID: 30625143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential gene expression analysis in ageing muscle and drug discovery perspectives.
    Melouane A; Ghanemi A; Aubé S; Yoshioka M; St-Amand J
    Ageing Res Rev; 2018 Jan; 41():53-63. PubMed ID: 29102726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is anti-ageing drug discovery becoming a reality?
    Moskalev A
    Expert Opin Drug Discov; 2020 Feb; 15(2):135-138. PubMed ID: 31822135
    [No Abstract]   [Full Text] [Related]  

  • 7. Rationale and methods of discovering hormetins as drugs for healthy ageing.
    Rattan SI
    Expert Opin Drug Discov; 2012 May; 7(5):439-48. PubMed ID: 22509769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The quest to slow ageing through drug discovery.
    Partridge L; Fuentealba M; Kennedy BK
    Nat Rev Drug Discov; 2020 Aug; 19(8):513-532. PubMed ID: 32467649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Geroneuroprotectors: Effective Geroprotectors for the Brain.
    Schubert D; Currais A; Goldberg J; Finley K; Petrascheck M; Maher P
    Trends Pharmacol Sci; 2018 Dec; 39(12):1004-1007. PubMed ID: 30446211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic Manipulation of Ageing: Repurposing Old Dogs and Discovering New Tricks.
    Mallikarjun V; Swift J
    EBioMedicine; 2016 Dec; 14():24-31. PubMed ID: 27889480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug discovery and development for ageing: opportunities and challenges.
    Evans WJ
    Philos Trans R Soc Lond B Biol Sci; 2011 Jan; 366(1561):113-9. PubMed ID: 21115538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drugs that target aging: how do we discover them?
    Myers A; Lithgow GJ
    Expert Opin Drug Discov; 2019 Jun; 14(6):541-548. PubMed ID: 30973028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Challenges with risk mitigation in academic drug discovery: finding the best solution.
    Roy A
    Expert Opin Drug Discov; 2019 Feb; 14(2):95-100. PubMed ID: 30513005
    [No Abstract]   [Full Text] [Related]  

  • 14. Experimental Models for Aging and their Potential for Novel Drug Discovery.
    Folch J; Busquets O; Ettcheto M; Sánchez-López E; Pallàs M; Beas-Zarate C; Marin M; Casadesus G; Olloquequi J; Auladell C; Camins A
    Curr Neuropharmacol; 2018; 16(10):1466-1483. PubMed ID: 28685671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current challenges in drug discovery for tuberculosis.
    Kumar A; Chettiar S; Parish T
    Expert Opin Drug Discov; 2017 Jan; 12(1):1-4. PubMed ID: 27797593
    [No Abstract]   [Full Text] [Related]  

  • 16. Challenges for academic drug discovery.
    Jorgensen WL
    Angew Chem Int Ed Engl; 2012 Nov; 51(47):11680-4. PubMed ID: 23097176
    [No Abstract]   [Full Text] [Related]  

  • 17. Repurposing FDA-approved drugs for anti-aging therapies.
    Snell TW; Johnston RK; Srinivasan B; Zhou H; Gao M; Skolnick J
    Biogerontology; 2016 Nov; 17(5-6):907-920. PubMed ID: 27484416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome-environment interactions that modulate aging: powerful targets for drug discovery.
    de Magalhães JP; Wuttke D; Wood SH; Plank M; Vora C
    Pharmacol Rev; 2012 Jan; 64(1):88-101. PubMed ID: 22090473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical strategies and animal models for developing senolytic agents.
    Kirkland JL; Tchkonia T
    Exp Gerontol; 2015 Aug; 68():19-25. PubMed ID: 25446976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autophagy in ageing and ageing-associated diseases.
    He LQ; Lu JH; Yue ZY
    Acta Pharmacol Sin; 2013 May; 34(5):605-11. PubMed ID: 23416930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.